Atea Pharmaceuticals (AVIR) Stock Price & Financial Analysis
Atea Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Atea Pharmaceuticals
What is the current stock price for AVIR?
As of the latest trading session, AVIR stock trades at $5.76. The 52-week range is $2.46–$6.45, with a day range of $5.50–$5.84.
What is the P/E ratio for AVIR?
The P/E ratio (Price-to-Earnings) for AVIR is shown in the Key Statistics section. This valuation metric helps compare Atea Pharmaceuticals, Inc. to industry peers.
Does AVIR pay dividends?
Atea Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for AVIR?
Based on 1 analyst, the consensus for AVIR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of AVIR?
Atea Pharmaceuticals's market capitalization is $450.0M, classifying it as a small-cap company. Atea Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.